NASDAQ:SIEN - Sientra Stock Price, Forecast & News

Sientra trades on the NASDAQ under the ticker symbol "SIEN."

Sientra Inc (NASDAQ:SIEN) released its earnings results on Thursday, November, 7th. The medical instruments supplier reported ($0.45) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.47) by $0.02. The medical instruments supplier earned $22.41 million during the quarter, compared to the consensus estimate of $20.05 million. Sientra had a negative net margin of 143.76% and a negative return on equity of 122.95%. Sientra's revenue was up 32.8% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.72) earnings per share. View Sientra's Earnings History.

Sientra is scheduled to release their next quarterly earnings announcement on Tuesday, March 10th 2020. View Earnings Estimates for Sientra.

Sientra issued an update on its fourth quarter 2019 Pre-Market earnings guidance on Monday, January, 13th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $23.2-23.2 million, compared to the consensus revenue estimate of $22.74 million.

8 analysts have issued 12-month price objectives for Sientra's stock. Their forecasts range from $10.00 to $27.00. On average, they anticipate Sientra's share price to reach $15.75 in the next year. This suggests a possible upside of 167.9% from the stock's current price. View Analyst Price Targets for Sientra.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sientra in the last year. There are currently 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Sientra.

News headlines about SIEN stock have been trending negative recently, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Sientra earned a media sentiment score of -2.7 on InfoTrie's scale. They also gave media stories about the medical instruments supplier a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the next several days. View News Stories for Sientra.

Some companies that are related to Sientra include Inogen (INGN), Establishment Labs (ESTA), RTI Surgical (RTIX), Invacare (IVC), Lakeland Industries (LAKE), ConforMIS (CFMS), Histogenics (HSGX), COLLPLANT HOLDI/S (CLGN), Bionik Laboratories (BNKL), NanoVibronix (NAOV), Precision Therapeutics (POAI), Allied Healthcare Products (AHPI), Ocugen (OCGN), Rewalk Robotics (RWLK) and Avitar (AVTI).

Based on aggregate information from My MarketBeat watchlists, some companies that other Sientra investors own include Genocea Biosciences (GNCA), Novavax (NVAX), Verizon Communications (VZ), Rigel Pharmaceuticals (RIGL), Regions Financial (RF), Anavex Life Sciences (AVXL), Baidu (BIDU), ChemoCentryx (CCXI), Idera Pharmaceuticals (IDRA) and Opko Health (OPK).

Sientra's stock is owned by a variety of of retail and institutional investors. Top institutional investors include UBS Group AG (4.84%), Schroder Investment Management Group (3.78%), Bamco Inc. NY (2.84%), Goldman Sachs Group Inc. (2.61%), Broadfin Capital LLC (2.60%) and UBS Asset Management Americas Inc. (2.16%). Company insiders that own Sientra stock include Jeffrey M Nugent, Keith J Sullivan, Patrick F Williams, Paul Sean Little, R Scott Greer and Timothy Haines. View Institutional Ownership Trends for Sientra.

SIEN stock was sold by a variety of institutional investors in the last quarter, including Broadfin Capital LLC, J. Goldman & Co LP, UBS Group AG, Barclays PLC, Bamco Inc. NY, Schroder Investment Management Group, Millrace Asset Group Inc. and Private Advisor Group LLC. View Insider Buying and Selling for Sientra.

SIEN stock was purchased by a variety of institutional investors in the last quarter, including Monarch Partners Asset Management LLC, EAM Investors LLC, Assenagon Asset Management S.A., EAM Global Investors LLC, State Street Corp, Marshall Wace North America L.P., Granite Point Capital Management L.P. and Bank of New York Mellon Corp. Company insiders that have bought Sientra stock in the last two years include Jeffrey M Nugent, Keith J Sullivan, Patrick F Williams, Paul Sean Little, R Scott Greer and Timothy Haines. View Insider Buying and Selling for Sientra.

Shares of SIEN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of SIEN stock can currently be purchased for approximately $5.88.

Sientra has a market capitalization of $290.95 million and generates $68.13 million in revenue each year. The medical instruments supplier earns $-82,630,000.00 in net income (profit) each year or ($3.25) on an earnings per share basis. Sientra employs 259 workers across the globe.View Additional Information About Sientra.

The official website for Sientra is http://www.sientra.com/.

Sientra's mailing address is 420 SOUTH FAIRVIEW AVENUE SUITE 200, SANTA BARBARA CA, 93117. The medical instruments supplier can be reached via phone at 805-562-3500 or via email at [email protected]